LIFE Share Price Performance
₽0
0.00 (0.00%)
Price ₽0
Share Pricen/a
Public Joint-Stock Company "Pharmsynthez" Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
LIFE Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Public Joint-Stock Company "Pharmsynthez" Key Details
Last Reported Earnings
Jun 30, 2021
Next Reporting Earnings
n/a
- -2.22
- 45.85%
- -148.38%
- 86.9%
About LIFE
- Founded
- 1996
- Employees
- n/a
- CEO
- WebsiteView website
Public Joint-Stock Company ‘Pharmsynthez’, a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company ‘Pharmsynthez’ has partnership with HiFiBiO Therapeutics Inks for the clinical development and commercialization of its SARS-CoV-2 neutralizing antibody in Russia. Public Joint-Stock Company ‘Pharmsynthez’ was founded in 1996 and is based in St. Petersburg, Russia.